Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects

NCT01540864 is registered in ClinicalTrials.gov with High Point Pharmaceuticals, LLC. as lead sponsor.

NCT NCT01540864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01540864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 26 Week Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Various Doses of HPP404 on Weight Loss in Overweight or Obese Subjects
Lead sponsor
High Point Pharmaceuticals, LLC.
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2012
Completion date
May 31, 2013
Enrollment
126 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight